Evidence map›Paper›PMID 23456270›Full record

ArticleCancer causes & control : CCC2013

Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies.

Mette T Faber, Susanne K Kjær, Christian Dehlendorff, Jenny Chang-Claude, Klaus K Andersen, Estrid Høgdall, Penelope M Webb, Susan J Jordan, Australian Cancer Study (Ovarian Cancer), Australian Ovarian Cancer Study Group and 51 more

Open access · greenAbstract read
In one paragraph

Article in Cancer causes & control : CCC, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 6 pooled it
11.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 6 syntheses or guidelines pooled it, 111 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Cellular origins of mucinous ovarian carcinoma.The Journal of pathology · 2025
    Review
  14. Timing of depression in relation to risk of ovarian cancer.Journal of the National Cancer Institute · 2025
    Article
  15. Review
  16. Article
  17. Article
  18. Global epidemiology of epithelial ovarian cancer.Nature reviews. Clinical oncology · 2024
    Review
  19. Risk Factors for Ovarian Cancer by BRCA Status: A Collaborative Case-Only Analysis.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2024
    Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

61 authors at 20 institutions in 7 countries.

Mette T FaberUnit of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Strandboulevarden 49, 2100, Copenhagen, Denmark.
Susanne K Kjær
Christian Dehlendorff
Jenny Chang-Claude
Klaus K Andersen
Estrid Høgdall
Penelope M Webb
Susan J Jordan
Australian Cancer Study (Ovarian Cancer)
Australian Ovarian Cancer Study Group
Mary Anne Rossing
Jennifer A Doherty
Galina Lurie
Pamela J Thompson
Michael E Carney
Marc T Goodman
Roberta B Ness
Francesmary Modugno
Robert P Edwards
Clareann H Bunker
Ellen L Goode
Brooke L Fridley
Robert A Vierkant
Melissa C Larson
Joellen Schildkraut
Daniel W Cramer
Kathryn L Terry
Allison F Vitonis
Elisa V Bandera
Sara H Olson
Melony King
Urmila Chandran
Lambertus A Kiemeney
Leon F A G Massuger
Anne M van Altena
Sita H Vermeulen
Louise Brinton
Nicolas Wentzensen
Jolanta Lissowska
Hannah P Yang
Kirsten B Moysich
Kunle Odunsi
Karin Kasza
Oluwatosin Odunsi-Akanji
Honglin Song
Paul Pharaoh
Mitul Shah
Alice S Whittemore
Valerie McGuire
Weiva Sieh
Rebecca Sutphen
Usha Menon
Simon A Gayther
Susan J Ramus
Aleksandra Gentry-Maharaj
Celeste Leigh Pearce
Anna H Wu
Malcolm C Pike
Harvey A Risch
Allan Jensen
Ovarian Cancer Association Consortium
University of Southern California · USRoswell Park Comprehensive Cancer Center · USRadboud University Nijmegen · NLRutgers, The State University of New Jersey · USUniversity of Hawaiʻi at Mānoa · USDanish Cancer Society · DKBrigham and Women's Hospital · USQIMR Berghofer Medical Research Institute · AUUniversity of Cambridge · GBMayo Clinic · USNational Cancer Institute · USUniversity of Copenhagen · DKUniversity of Pittsburgh · USYale University · USCopenhagen University Hospital · DKDartmouth College · USDuke Medical Center · USGerman Cancer Research Center · DELondon Women's Clinic · GBMayo Clinic in Florida · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORTP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Fumito Ito · 1985 to 2026
$181.4M
Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MARK G FRATTINI · 1985 to 2026
$116.6M
Hormone-Related CancersZIACP010126 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI GIERACH, GRETCHEN · 2009 to 2025
$103.5M
Use of microfluidic tumor cultures to enable clinical trials of therapies for ovarian cancerP50CA136393 · NCI · MAYO CLINIC ROCHESTER · PI Zhenkun Lou · 2009 to 2026
$37.0M
Northern California Cooperative Family Registry for Breast CancerU01CA069417 · NCI · NORTHERN CALIFORNIA CANCER CENTER · PI JOHN, ESTHER M. · 1995 to 2010
$22.4M
USC CANCER EPIDEMIOLOGY &BIOSTATISTICS UNITP01CA017054 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI STRAM, DANIEL O · 1985 to 2009
$18.2M
Novel Serum, Plasma, and Urine Biomarkers of Ovarian CanP50CA105009 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI CRAMER, DANIEL WILLIAM · 2004 to 2010
$13.3M
The Molecular Epidemiology Of Ovarian CancerR01CA076016 · NCI · DUKE UNIVERSITY · PI SCHILDKRAUT, JOELLEN M. · 1998 to 2010
$6.2M
OVARIAN CANCER RISK AND HYPERGONADOTROPIC HYPOGONADISMR01CA054419 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI CRAMER, DANIEL WILLIAM · 1992 to 2007
$5.9M
COLLABORATIVE STUDY OF OVARIAN CANCER IN TWO RISK GROUPSR01CA058598 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI GOODMAN, MARC T · 1993 to 2012
$4.6M
Epidemiology of Ovarian Cancer:New HypothesesR01CA087538 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ROSSING, MARY ANNE · 2002 to 2006
$3.5M
Cancer Research UK 10119Cancer Research UK 10124Cancer Research UK 16561Cancer Research UK C490/A10119Cancer Research UK C490/A10124NCI NIH HHS CA14089NCI NIH HHS CA17054NCI NIH HHS CA61132NCI NIH HHS CA 8860NCI NIH HHS CA92044NCI NIH HHS K07 CA092044NCI NIH HHS K07 CA095666NCI NIH HHS K07 CA143047NCI NIH HHS K22 CA138563NCI NIH HHS N01 CN025403NCI NIH HHS N01 CN25403NCI NIH HHS N01 CN55424NCI NIH HHS N01 PC067010NCI NIH HHS N01 PC67001NCI NIH HHS P01 CA017054NCI NIH HHS P01 CA17054NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA014089NCI NIH HHS P30 CA016056NCI NIH HHS P50 CA105009NCI NIH HHS P50 CA136393NCI NIH HHS R01 CA054419NCI NIH HHS R01 CA058598NCI NIH HHS R01 CA063678NCI NIH HHS R01 CA063682NCI NIH HHS R01 CA074850NCI NIH HHS R01 CA076016NCI NIH HHS R01 CA080742NCI NIH HHS R01 CA080978NCI NIH HHS R01 CA083918NCI NIH HHS R01 CA087538NCI NIH HHS R01 CA095023NCI NIH HHS R01 CA106414NCI NIH HHS R01 CA112523NCI NIH HHS R01 CA122443NCI NIH HHS R01 CA16056NCI NIH HHS R01 CA54419NCI NIH HHS R01 CA58598NCI NIH HHS R01 CA61107NCI NIH HHS R01 CA76016NCI NIH HHS R01 CA83918NCI NIH HHS R01 CA87538NCI NIH HHS R01 CA95023NCI NIH HHS R03 CA113148NCI NIH HHS R03 CA115195NCI NIH HHS U01 CA069417NCI NIH HHS U01 CA071966NCI NIH HHS U01 CA69417NCI NIH HHS U01 CA71966
6 · The paper itself

Abstract

purposeThe majority of previous studies have observed an increased risk of mucinous ovarian tumors associated with cigarette smoking, but the association with other histological types is unclear. In a large pooled analysis, we examined the risk of epithelial ovarian cancer associated with multiple measures of cigarette smoking with a focus on characterizing risks according to tumor behavior and histology.

methodsWe used data from 21 case-control studies of ovarian cancer (19,066 controls, 11,972 invasive and 2,752 borderline cases). Study-specific odds ratios (OR) and 95 % confidence intervals (CI) were obtained from logistic regression models and combined into a pooled odds ratio using a random effects model.

resultsCurrent cigarette smoking increased the risk of invasive mucinous (OR = 1.31; 95 % CI: 1.03-1.65) and borderline mucinous ovarian tumors (OR = 1.83; 95 % CI: 1.39-2.41), while former smoking increased the risk of borderline serous ovarian tumors (OR = 1.30; 95 % CI: 1.12-1.50). For these histological types, consistent dose-response associations were observed. No convincing associations between smoking and risk of invasive serous and endometrioid ovarian cancer were observed, while our results provided some evidence of a decreased risk of invasive clear cell ovarian cancer.

conclusionsOur results revealed marked differences in the risk profiles of histological types of ovarian cancer with regard to cigarette smoking, although the magnitude of the observed associations was modest. Our findings, which may reflect different etiologies of the histological types, add to the fact that ovarian cancer is a heterogeneous disease.

Indexed as

AdolescentAdultAgedAged, 80 and overCarcinoma, Ovarian EpithelialCase-Control StudiesFemaleHumansLogistic ModelsMiddle AgedNeoplasms, Glandular and EpithelialOvarian NeoplasmsRisk FactorsSmokingYoung Adult

Identifiers

PMID23456270
PMCPMC3818570
OpenAlexW2077168411

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.